Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
AK Medical Holdings Limited (1789 HK)
Watchlist
89
Analysis
Health Care
•
China
Specializes in the research, development, manufacture, and sale of artificial joint prostheses & their associated surgical instruments and applications
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Alibaba
•
02 Sep 2025 17:34
HSI, HSCEI, HSTECH, HSIII Index Rebalance: US$7.4bn of Flows Post Capping (Sep 2025)
The Sep rebalance of the HSI, HSCEI, HSTECH, HSIII, HSHKBIO indices will use today's closing prices for capping. The round-trip trade across the...
Brian Freitas
Follow
1.2k Views
Share
bearish
•
Giant Biogene
•
23 Aug 2025 09:26
Hang Seng Biotech Index Rebalance: 1 Add & 21 Deletes as Methodology Changes
There is 1 add and 21 deletes for the HSHKBIO in Sep. Couple of surprises. Estimated one-way turnover at the rebalance is 11.25% resulting in a...
Brian Freitas
Follow
767 Views
Share
bullish
•
Pop Mart
•
21 Aug 2025 05:30
Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows
Hang Seng announces after market close on Friday. The net round-trip trade across the stocks is estimated at HK$54.3bn. There is positioning in the...
Brian Freitas
Follow
1.1k Views
Share
bearish
•
Consun Pharmaceutical
•
18 Aug 2025 19:01
Quiddity Leaderboard Hang Seng Biotech Sep25: Announcement Soon; MANY DELs Likely!
There are 20 deletions expected due to drastic changes to the index selection methodology. These names have underperformed the index in the last...
Janaghan Jeyakumar, CFA
Follow
569 Views
Share
bullish
•
Quantitative Analysis
•
17 Aug 2025 10:05
HK Connect Flows Weekly (Aug 15th): Xiaomi, Kuaishou, Wuxi Biologics, Alibaba, BYD Electronic, Anta
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Xiaomi, Kuaishou, Wuxi Biologics, Alibaba, BYD...
Ke Yan, CFA, FRM
Follow
1.6k Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x